1. Lymphocyte subset (CD4+, CD8+) counts reflect the severity of infection and predict the clinical outcomes in patients with COVID-19;Liu;J Infect,2020
2. T cell subset counts in peripheral blood can be used as discriminatory biomarkers for diagnosis and severity prediction of COVID-19;Jiang;J Infect Dis,2020
3. National Health Commission of the People's Republic of China. Guidelines for the Diagnosis and Treatment of COVID-19 (Trial Version 7). 2020.http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989/files/ce3e6945832a438eaae415350a8ce964.pdf. Accessed Jun 16,2020.
4. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients;Urra;Clin Immunol (Orlando, Fla),2020
5. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19);Diao;Clin Transl Immunol,2020